Paper39796151
Assessment of Hypercoagulability in Splanchnic Vein Thrombosis by Measurement of the Hemostasis Enzymes Thrombin and Activated Protein C.
Reda S and 10 others. Int J Mol Sci, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Assessment of Hypercoagulability in Splanchnic Vein Thrombosis by Measurement of the Hemostasis Enzymes Thrombin and Activated Protein C. Papers, record 39796151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39796151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Assessment of Hypercoagulability in Splanchnic Vein Thrombosis by Measurement of the Hemostasis Enzymes Thrombin and Activated Protein C.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein C | Major topic |
| Thrombin | Major topic |
| Venous Thrombosis | Major topic |
| Thrombophilia | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Aged | |
| Adult | |
| Biomarkers | |
| Hemostasis | |
| Case-Control Studies | |
| Myeloproliferative Disorders | |
| Splanchnic Circulation | |
| Blood Coagulation |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24879813 | D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. | Blood | 2014 | https://conductscience.org/library/papers/24879813 | PubMed |
| 2 | 26076949 | Epidemiology of venous thromboembolism. | Nat Rev Cardiol | 2015 | https://conductscience.org/library/papers/26076949 | PubMed |
| 3 | 18725614 | Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. | CMAJ | 2008 | https://conductscience.org/library/papers/18725614 | PubMed |
| 4 | 29643232 | Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. | Sci Transl Med | 2018 | https://conductscience.org/library/papers/29643232 | PubMed |
| 5 | 22236082 | Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay. | J Thromb Haemost | 2012 | https://conductscience.org/library/papers/22236082 | PubMed |
| 6 | 20546119 | Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. | J Thromb Haemost | 2010 | https://conductscience.org/library/papers/20546119 | PubMed |
| 7 | 30171023 | Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression. | Haematologica | 2019 | https://conductscience.org/library/papers/30171023 | PubMed |
| 8 | 35433891 | Increased Prevalence of Elevated D-Dimer Levels in Patients on Direct Oral Anticoagulants: Results of a Large Retrospective Study. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35433891 | PubMed |
| 9 | 33567864 | Cancer Therapy-Associated Thrombosis. | Arterioscler Thromb Vasc Biol | 2021 | https://conductscience.org/library/papers/33567864 | PubMed |
| 10 | 7989361 | The mechanism of inactivation of human factor V and human factor Va by activated protein C. | J Biol Chem | 1994 | https://conductscience.org/library/papers/7989361 | PubMed |
| 11 | 11238108 | Endothelial cell protein C receptor plays an important role in protein C activation in vivo. | Blood | 2001 | https://conductscience.org/library/papers/11238108 | PubMed |
| 12 | 19105233 | Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. | Am J Hematol | 2009 | https://conductscience.org/library/papers/19105233 | PubMed |
| 13 | 18768782 | Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. | Blood | 2008 | https://conductscience.org/library/papers/18768782 | PubMed |
| 14 | 31314700 | Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers. | Circ Res | 2019 | https://conductscience.org/library/papers/31314700 | PubMed |
| 15 | 2538457 | The roles of protein C and thrombomodulin in the regulation of blood coagulation. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2538457 | PubMed |
| 16 | 1643210 | Antithrombin and its deficiency states. | Blood Coagul Fibrinolysis | 1992 | https://conductscience.org/library/papers/1643210 | PubMed |
| 17 | 35120736 | Baveno VII - Renewing consensus in portal hypertension. | J Hepatol | 2022 | https://conductscience.org/library/papers/35120736 | PubMed |
| 18 | 26080307 | Splanchnic Vein Thrombosis. | Semin Thromb Hemost | 2015 | https://conductscience.org/library/papers/26080307 | PubMed |
| 19 | 20656333 | Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms. | Thromb Res | 2010 | https://conductscience.org/library/papers/20656333 | PubMed |
| 20 | 31722081 | Characterization of circulating thrombin in patients with septic shock: a prospective observational study. | J Thromb Thrombolysis | 2020 | https://conductscience.org/library/papers/31722081 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42768164 | A two-step model of age-associated autoreactivity: B cell-intrinsic aging meets inflammaging. | Geroscience | 2026 | https://conductscience.org/library/papers/42768164 | PubMed |
| 40869123 | Special Issue "Advances in Coagulation and Anticoagulation". | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869123 | PubMed |
| 40100360 | MTDH inhibits CrAT to promote mitochondrial damage in palmitic acid-induced renal tubular cells. | Acta Diabetol | 2026 | https://conductscience.org/library/papers/40100360 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| PC | 5091 | PubTator's text mining | https://conductscience.org/library/genes/5091 | NCBI Gene |
| PROC | 5624 | PubTator's text mining | https://conductscience.org/library/genes/5624 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39796151
GET https://conductscience.org/api/papers/v1/39796151/references?page=2